Founders Factory partnership accelerates
In late 2025 MSWA announced the world first joint venture with Founders Factory, joining forces to back breakthrough technologies in neurological care.
Excitingly, we can now announce the first startups joining the Neurological Care Accelerator, the first dedicated startup programme created to fast-track revolutionary technologies that can change quality of life for those living with neurological conditions.
The Neurological Care Tech Accelerator is helping close a major gap in global health tech investment, supporting the next generation of healthcare solutions for the millions of people living with some of the world’s fastest-growing neurological conditions.
At the heart of the programme is hands-on support designed to help promising innovations reach Clients sooner. Selected ventures will have the opportunity to work closely with MSWA’s extensive clinical network and our community of thousands –testing and piloting solutions in real-world settings.
“Founders Factory’s global model enables entrepreneurs and clinicians to work side-by-side, translating complex ideas into practical solutions that can be adopted sooner, and importantly, in ways that respond to real Client needs,” said MSWA CEO, Melanie Kiely.
“Ultimately, programs like this allow people with neurological conditions right here in WA to have first access to world-leading technology.”
Each selected early-stage venture uses emerging technologies – from brain-computer interfaces, AI and robotics to wearables and remote health monitoring tools – to develop new ways of caring for and supporting people living with neurological and physical challenges.
The five selected ventures includes:
- upLYFT (London): Uplyft integrates sensors into everyday textiles to track user movement and health data invisibly, supporting rehabilitation and performance monitoring.
- Neurosonic (San Francisco): Detects and monitors carotid artery stenosis using blood-flow acoustics, enabling early stroke prevention interventions.
- Fluent (Melbourne): Fluent is developing a subscalp brain-computer interface that decodes speech signals for patients with severe communication impairments.
- Clarity Technologies (San Francisco, Paris): Clarity creates wearable devices delivering targeted sensory stimulation therapy to reduce fatigue and improve cognitive function in neurodegenerative diseases.
- ReVimo (Boston): Portable robotic self-transfer device that enables individuals with mobility impairments to get out of bed and perform self-care tasks safely and independently.
Behind the curtain at the Perth Residency Week
In late May, Founders Factory, the teams behind the five ventures, and MSWA came together for the immersive Perth Residency Week, with the group receiving an intensive introduction to all things MSWA and neurological care.
Across the week, the Founders toured MSWA sites and met Clients, giving them a first-hand look of the amazing technologies they are developing. There were many pitches, panels, trials and meetings, all of which abled the Founders to work with our clinical network and community, allowing them to test and pilot their technologies in real-world settings.
In attendance throughout the week was NeuroSonic, co-founded by Irish biomedical engineers Mike Ryan and Mathew Campbell. They have developed a rapid, non-invasive stroke risk assessment technology, which analyses blood flow in the carotid arteries to flag patients before symptoms appear. This can help clinicians intervene early before severe outcomes occur.
“Our goal is simple – preventing strokes through timely detection. Partnering with MSWA and Founders Factory has directly embedded us into the Australian health ecosystem, connecting us to clinicians, patients and policymakers,” Mike, CEO of NeuroSonic states.
For MSWA Client Miles, the relevance is personal after suffering a severe stroke in 2016.
“After my stroke, I spent four months in Fiona Stanley Hospital and six months in a wheelchair. If earlier detection like NeuroSonic’s had been available, my rehab might have been a completely different story,” he said.
Knowing others could avoid going through what I did, that means everything."
During the week, the Founders all individually pitched to Clients in both Butler and Wilson, many of which were met with applause and cheers. The future impact of these ventures is clear and we thank all who got involved, were curious and wanted to know more about the amazing tech.
We know the Neurological Care Tech Accelerator programme will have a profound impact on the WA neuro community and beyond, and we look forward to seeing what the future holds. Watch this space!
